Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diagnostics
Company gets U.S. FDA clearance for STD testing with APTIMA Combo 2 assay
September 8th, 2005
Gen-Probe, Inc., (GPRO) and Cytyc Corp. (CYTC) announced that the U.S. Food and Drug Administration (FDA) has granted marketing clearance to use Gen-Probe's APTIMA Combo 2 assay to test for Chlamydia trachomatis and Neisseria gonorrhoeae from liquid Pap specimens collected and processed with Cytyc's ThinPrep 2000 System. "This new indication for the APTIMA Combo 2 assay adds to the comprehensive solution that Gen-Probe offers customers for STD [sexually transmitted disease] testing," said Steve Kondor, vice president of sales and marketing for Gen-Probe. "In addition, it provides physicians the convenience of intercepting Chlamydia infections and gonorrhea...
Source: Women's Health Weekly (2005-09-08)
|
